Related Experiment Video
Updated: Sep 27, 2026

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
Published on: July 10, 2018
The upper and lower airway responses to nasal challenge with house-dust mite Blomia tropicalis
D Y Wang1, D Y T Goh, A K L Ho
1Department of Otolaryngology, The National University of Singapore, Singapore.
Background:
The house dust mite Blomia tropicalis (B. tropicalis) was found to be the most prevalent domestic mite in Singapore. However, its pathogenicity in allergic airway diseases remains to be investigated.
Methods:
Twenty adults with persistent allergic rhinitis (PAR) were studied. Five had a history of asthma, and all were asymptomatic except one who was under treatment with low-dose inhaled corticosteroid. Nasal challenge was carried out by nasal spray with phosphate-buffered saline (PBS) and with increasing concentrations of crude B. tropicalis extracts (0.6, 6.0 and 60 micro g/ml) at 15 min intervals. Subjective symptom scores and absolute number of sneezes were recorded together with objective measurements of spirometry (forced expiratory volume in 1 s, FEV1) and acoustic rhinomanometry (volume of the nasal cavity). These were performed at baseline, 5 min after each incremental challenge, and 30 min, 1 h, 3 h, 5 h and 7 h after the last challenge. Meanwhile, concentrations of mediators in nasal secretions (tryptase, leukotriene C4 (LTC4) and eosinophil cationic protein (ECP)) were measured in nasal aspirate samples at similar time intervals. An identical (control) challenge procedure with PBS alone was repeated in seven patients after a washout period of at least 2 weeks.
Results:
Significant increases in the subjective and objective nasal symptoms, together with a significant increase of tryptase and LTC4 concentrations in nasal secretion, were found 5 min after each challenge with B. tropicalis, but not with PBS. There was no definitive pattern of the late-phase nasal response in either subjective symptoms or objective measurements. Three patients (3/5) with a history of asthma showed a fall in FEV1 readings (33%, 22% and 11% from baseline, respectively) at 7 h post challenge with concomitant mild wheezing in the night.
Conclusions:
Our study demonstrates direct evidence of allergic nasal response to B. tropicalis in sensitized adults. It shows that nasal provocation may also provoke concomitant asthmatic symptoms during the late-phase reaction, especially in people with a history of asthma.
Insights
This study shows that the house dust mite Blomia tropicalis triggers allergic nasal responses in sensitized adults. Nasal challenges with this mite can also lead to asthma symptoms, particularly in those with a history of asthma.
Area of Science:
- Allergy and Immunology
- Respiratory Medicine
- Environmental Health
Background:
- Blomia tropicalis is the most common domestic mite in Singapore.
- Its role in allergic airway diseases requires investigation.
Purpose of the Study:
- To investigate the pathogenicity of Blomia tropicalis in adults with persistent allergic rhinitis.
- To assess the direct allergic nasal response to B. tropicalis.
Main Methods:
- Nasal challenge tests were performed on 20 adults with persistent allergic rhinitis using B. tropicalis extracts.
- Subjective and objective nasal symptoms, spirometry (FEV1), and nasal mediator concentrations (tryptase, LTC4, ECP) were measured.
- Control challenges with phosphate-buffered saline (PBS) were conducted.
Main Results:
- B. tropicalis challenge caused significant increases in nasal symptoms and mediator concentrations.
- No consistent late-phase nasal response was observed.
- Three out of five patients with asthma history experienced decreased FEV1 and mild wheezing post-challenge.
Conclusions:
- Direct evidence of allergic nasal response to B. tropicalis in sensitized adults was demonstrated.
- Nasal provocation with B. tropicalis may trigger asthma symptoms, especially in individuals with pre-existing asthma.
Related Concept Videos
Microbiota of the Respiratory Tract
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
